UPDATE: Roche's New Diabetes Drug Works Better Than Byetta

Here's an article about taspoglutide and you don't have to subscribe to the WSJ to read it: ZURICH -(Dow Jones)- Roche Holding AG said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. in lowering blood sugar, according to the results of a late stage study. October 29, 2009: 08:19 AM ET